Sanofi-Aventis Stops Development of Two Medicines

Sanofi-Aventis SA stopped tests on two medicines for insomnia and atrial fibrillation because of setbacks in development and said it is making progress with potential drugs to prevent clots and treat prostate cancer.
Bloomberg